KIDS OrthoPediatrics Corp

OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

OrthoPediatrics Corp. Joins Crossroads Pediatric Device Consortium to Advance Pediatric Medical Device Innovation

WARSAW, Ind., March 17, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its partnership with the Crossroads Pediatric Device Consortium (CPDC). This collaboration aligns with the Company’s cause of improving the lives of children by supporting the development and commercialization of innovative pediatric medical devices.​

The Crossroads Pediatric Device Consortium is a multi-institutional initiative focused on accelerating the development, approval, and availability of medical devices designed specifically for pediatric patients. Founding members include Purdue University’s Weldon School of Biomedical Engineering, the Indiana University School of Medicine’s Department of Pediatrics, and Cook Medical, a leader in medical device manufacturing. OrthoPediatrics' addition to the consortium brings specialized expertise in pediatric orthopedics, further strengthening the consortium's capabilities to develop and commercialize pediatric medical devices.

“We are proud to join the Crossroads Pediatric Device Consortium, as it aligns with our cause of advancing healthcare for KIDS all over the world,” said David Bailey, President & CEO of OrthoPediatrics. “By collaborating with CPDC's network of experts, we aim to drive innovation in pediatric medical technology and ensure children have access to the specialized treatments they need.”​

Matthew Waninger, Managing Director of Crossroads Pediatric Device Consortium, welcomed the partnership, stating: “OrthoPediatrics has been a leader in pediatric orthopedics for years, and we are thrilled to have them as part of our consortium. Their expertise and dedication to pediatric innovation will be invaluable as we work to accelerate the development and accessibility of breakthrough medical devices for children.”​

With OrthoPediatrics joining, the Crossroads Pediatric Device Consortium strengthens its industry partnerships through a distinctive model that directly integrates major medical device companies. By integrating industry leaders into its network, the consortium streamlines product development, regulatory navigation, and commercialization, ensuring pediatric medical innovations move efficiently from concept to market.

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 75 surgical systems that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit .

About Crossroads Pediatric Device Consortium (CPDC)

The Crossroads Pediatric Device Consortium is a collaborative initiative between Purdue University’s Weldon School of Biomedical Engineering, the Indiana University School of Medicine’s Department of Pediatrics, and Cook Medical. Crossroads Pediatric Device Consortium aims to bridge the gap between research, clinical needs, and industry by fostering partnerships that accelerate the development, approval, and commercialization of pediatric medical devices.

Investor Contact

Philip Trip Taylor

Gilmartin Group



415-937-5406



EN
17/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OrthoPediatrics Corp

 PRESS RELEASE

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annu...

OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor. At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including...

 PRESS RELEASE

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and...

OrthoPediatrics Corp. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Revenue Guidance First Quarter 2025 Revenue Increased 17% Year-over-Year WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 and Business Highlights Helped a record of nearly 39,000 children in the first quarter of 2025Generated total revenue of...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ ...

OrthoPediatrics Corp. Expands Trauma and Deformity Portfolio with 3P™ Pediatric Plating Platform™ Hip System WARSAW, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its Trauma and Deformity portfolio with 3P™ Pediatric Plating Platform™ Hip System, the first of several systems in the 3P family. This represents the company’s 5th FDA approval in 2025. 3P Pediatric Plating Platform Hip System is a new plate and scre...

 PRESS RELEASE

OrthoPediatrics Corp. to Report First Quarter Financial Results on May...

OrthoPediatrics Corp. to Report First Quarter Financial Results on May 7, 2025 WARSAW, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its first quarter 2025 financial results on May 7, 2025 after the market closes. OrthoPediatrics will host a conference call on Wednesday, May 7, 2025 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so...

 PRESS RELEASE

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of Verte...

OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System WARSAW, Ind., April 08, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the U.S. launch of the new VerteGlide Spinal Growth Guidance System, used to treat Early Onset Scoliosis (“EOS”). This represents the company’s 80th system designed to treat musculoskeletal issues in children. VerteGlide is a guided growth technology designed for children with Early Onset S...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch